Medicinal Chemistry Perspective on the Structure-activity Relationship of Stilbene Derivatives

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2024 Jun 21

PMID 38903666

Authors

Saghi Sepehri

Mina Khedmati

Faeze Yousef-Nejad

Mohammad Mahdavi

Affiliations

Soon will be listed here.

Abstract

Stilbenes are a small family of polyphenolic secondary metabolites produced in a variety of closely related plant species. These compounds function as phytoalexins, aiding plant defense against phytopathogens and plants' adaptation to abiotic environmental factors. Structurally, some important phenolic compounds have a 14-carbon skeleton and usually have two isomeric forms, and . Stilbenes contain two benzene rings linked by a molecule of ethanol or ethylene. Some derivatives of natural (poly)phenolic stilbenes such as resveratrol, pterostilbene, and combretastatin A-4 have shown various biological activities, such as anti-microbial, anti-cancer, and anti-inflammatory properties as well as protection against heart disease, Alzheimer's disease, and diabetes. Among stilbenes, resveratrol is certainly the most popular and extensively studied for its health properties. In recent years, an increasing number of stilbene compounds have been investigated for their bioactivity. This review focuses on the assessment of synthetic stilbene derivatives in terms of their biological activities and structure-activity relationship. The goal of this study is to consider the structural changes and different substitutions on phenyl rings that can improve the desired medicinal effects of stilbene-based compounds beyond the usual standards and subsequently discover biological activities by identifying effective alternatives of the evaluated compounds.

References

Aslam S, Stevenson P, Kokubun T, Hall D . Antibacterial and antifungal activity of cicerfuran and related 2-arylbenzofurans and stilbenes. Microbiol Res. 2007; 164(2):191-5. DOI: 10.1016/j.micres.2006.11.012. View

Jian W, He D, Song S . Synthesis, Biological Evaluation, and Molecular Modeling Studies of New Oxadiazole-Stilbene Hybrids against Phytopathogenic Fungi. Sci Rep. 2016; 6:31045. PMC: 4987640. DOI: 10.1038/srep31045. View

Pereira A, Arruda M, da Silva E, da Silva M, Lemos V, Cortes S . Inhibition of α-glucosidase and hypoglycemic effect of stilbenes from the Amazonian plant Deguelia rufescens var. urucu (Ducke) A. M. G. Azevedo (Leguminosae). Planta Med. 2011; 78(1):36-8. DOI: 10.1055/s-0031-1280199. View

Roupe K, Remsberg C, Yanez J, Davies N . Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol. 2008; 1(1):81-101. DOI: 10.2174/157488406775268246. View

Huang Z, Li G, Wang X, Xu H, Zhang Y, Gao Q . Deciphering the origins of molecular toxicity of combretastatin A4 and its glycoconjugates: interactions with major drug transporters and their safety profiles and . Medchemcomm. 2018; 8(7):1542-1552. PMC: 6072490. DOI: 10.1039/c7md00246g. View

Wen L, Jian W, Shang J, He D . Synthesis and antifungal activities of novel thiophene-based stilbene derivatives bearing an 1,3,4-oxadiazole unit. Pest Manag Sci. 2018; 75(4):1123-1130. DOI: 10.1002/ps.5229. View

Gosslau A, Pabbaraja S, Knapp S, Chen K . Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. Eur J Pharmacol. 2008; 587(1-3):25-34. DOI: 10.1016/j.ejphar.2008.03.027. View

Singh D, Mendonsa R, Koli M, Subramanian M, Nayak S . Antibacterial activity of resveratrol structural analogues: A mechanistic evaluation of the structure-activity relationship. Toxicol Appl Pharmacol. 2019; 367:23-32. DOI: 10.1016/j.taap.2019.01.025. View

Mizuno C, Ma G, Khan S, Patny A, Avery M, Rimando A . Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARalpha. Bioorg Med Chem. 2008; 16(7):3800-8. DOI: 10.1016/j.bmc.2008.01.051. View

10.

Kang S, Cuendet M, Endringer D, Croy V, Pezzuto J, Lipton M . Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg Med Chem. 2008; 17(3):1044-54. DOI: 10.1016/j.bmc.2008.04.031. View

11.

Li Y, Li Z, Zhao W, Wen R, Meng Q, Zeng Y . Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. Eur J Med Chem. 2006; 41(9):1084-9. PMC: 7119042. DOI: 10.1016/j.ejmech.2006.03.024. View

12.

Freyssin A, Page G, Fauconneau B, Rioux Bilan A . Natural stilbenes effects in animal models of Alzheimer's disease. Neural Regen Res. 2019; 15(5):843-849. PMC: 6990773. DOI: 10.4103/1673-5374.268970. View

13.

Zhang Y, Shen M, Cui S, Hou T . Synthesis and antiproliferative evaluation of 2-hydroxylated (E)-stilbenes. Bioorg Med Chem Lett. 2014; 24(23):5470-2. DOI: 10.1016/j.bmcl.2014.10.009. View

14.

Linkous A, Yazlovitskaya E . Novel therapeutic approaches for targeting tumor angiogenesis. Anticancer Res. 2012; 32(1):1-12. View

15.

Kachhadia V, Rajagopal S, Ponpandian T, Vignesh R, Anandhan K, Prabhu D . Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. Eur J Med Chem. 2015; 108:274-286. DOI: 10.1016/j.ejmech.2015.11.014. View

16.

Banik K, Ranaware A, Harsha C, Nitesh T, Girisa S, Deshpande V . Piceatannol: A natural stilbene for the prevention and treatment of cancer. Pharmacol Res. 2020; 153:104635. DOI: 10.1016/j.phrs.2020.104635. View

17.

McDonald O, Lackey K, Davis-Ward R, Wood E, Samano V, Maloney P . Aza-stilbenes as potent and selective c-RAF inhibitors. Bioorg Med Chem Lett. 2006; 16(20):5378-83. DOI: 10.1016/j.bmcl.2006.07.063. View

18.

Dirir A, Daou M, Yousef A, Yousef L . A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem Rev. 2021; 21(4):1049-1079. PMC: 8364835. DOI: 10.1007/s11101-021-09773-1. View

19.

Mikstacka R, Rimando A, Dutkiewicz Z, Stefanski T, Sobiak S . Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1. Bioorg Med Chem. 2012; 20(17):5117-26. DOI: 10.1016/j.bmc.2012.07.012. View

20.

Wolfe C, Pagano P, Pillar C, Shinabarger D, Boulos R . Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution. Diagn Microbiol Infect Dis. 2018; 92(3):250-252. DOI: 10.1016/j.diagmicrobio.2018.06.002. View